Robot-assisted pancreatoduodenectomy with the da Vinci Xi: can the costs of advanced technology be offset by clinical advantages? A case-matched cost analysis versus open approach.

Journal: Surgical endoscopy
Published Date: Oct 27, 2021

Abstract

BACKGROUND: Robot-assisted pancreatoduodenectomy (RPD) has shown some advantages over open pancreatoduodenectomy (OPD) but few studies have reported a cost analysis between the two techniques. We conducted a structured cost-analysis comparing pancreatoduodenectomy performed with the use of the da Vinci Xi, and the traditional open approach, and considering healthcare direct costs associated with the intervention and the short-term post-operative course.

Authors

  • Gregorio Di Franco
    General Surgery Unit, Department of Oncology, Transplantation and New Technologies, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Valentina Lorenzoni
    Institute of ManagementScuola Superiore Sant'Anna, Pisa, Italy.
  • Matteo Palmeri
    General Surgery Unit, Department of Oncology, Transplantation and New Technologies, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy. palmeri.matteo@gmail.com.
  • Niccolò Furbetta
    Department of Surgery, Translational and new Technologies in Medicine, University of Pisa, Pisa, Italy. n.furbetta@hotmail.it.
  • Simone Guadagni
    General Surgery Unit, Department of Oncology, Transplantation and New Technologies, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • DesirĂ©e Gianardi
    General Surgery Unit, Department of Surgery, Translational and New Technologies in Medicine, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy. gianardi.d@gmail.com.
  • Matteo Bianchini
    Department of Surgery, Translational and new Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Luca Emanuele Pollina
    Second Division of Surgical Pathology, University Hospital of Pisa, Pisa, Italy.
  • Franca Melfi
    Multidisciplinary Center of Robotic Surgery, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Domenica Mamone
    Pharmaceutical Unit: Medical Device Management, University Hospital of Pisa, Pisa, Italy.
  • Carlo Milli
    Board of Directors, University Hospital of Pisa, Pisa, Italy.
  • Giulio Di Candio
    General Surgery Unit, Department of Oncology, Transplantation and New Technologies, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Giuseppe Turchetti
    Institute of ManagementScuola Superiore Sant'Anna, Pisa, Italy.
  • Luca Morelli
    General Surgery Unit, Department of Oncology, Transplantation and New Technologies, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.

Keywords

External Resources

Popular Topics
Recent Journals